Liver transplantation for metastatic colon adenocarcinoma: report of a case with 10 years of follow-up without recurrence by Honore, Charles et al.
Introduction
Liver metastases are now considered an absolute con-
tra-indication to cadaveric liver transplantation (LT)
[1], with the relative exception of metastases of
symptomatic neuro-endocrine cancers [2]. Very few
short series of LT for secondary liver cancer were re-
ported in the late 1980s and early 1990s [3, 4], with
survival rates as low as 14% at 2 years and without
long-term cancer-free survival. The authors present,
herein, the case of a patient who has been enjoying 10
years of cancer-free survival after LT as rescue therapy
for acute liver failure after liver resection for isolated
hepatic metastasis of colon adenocarcinoma.
Case report
A man, born in 1946, was diagnosed as having a well-diﬀeren-
tiated adenocarcinoma of the sigmoid colon, staged B2 according
to the Dukes–Asler–Coller classiﬁcation. He underwent sigmoid
colon resection without adjuvant therapy in 1989. In 1992, a rise
in carcinoembryonic antigen (CEA) was noted, leading to the
diagnosis of an isolated, 5 cm-large hepatic metastasis (Fig. 1).
Partial hepatectomy, removing all of segment VIII and part of
segments IV, V, and VII, was performed under total vascular
exclusion. The procedure was complicated by early ischaemic
acute liver failure, leading to emergency LT. The patient did not
undergo any post-transplant chemotherapy. Ten years later,
the patient was free of cancer recurrence, as assessed by blood
CEA levels, thoracic and abdominal computed tomography, bone
scintigraphy, and positron emission tomodensitometry.
Discussion
Organ transplant recipients are prone to de novo cancer
development and pre-existing cancer recurrence. Among
other causes, immunosuppression has been related to
tumour occurrence or development, according to the
immune surveillance hypothesis that suggests that the
immune system might control cancer development [5].
Moreover, it has recently been suggested that cyclo-
sporine directly inﬂuences cancerous cells and induces
tumour progression by a cell-autonomous mechanism
that may be linked to the production of transforming
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Abstract Because of dismal mid-
term and long-term results, second-
ary liver cancer is considered an
absolute contra-indication to
cadaveric liver transplantation, with
the relative exception of metastases
of symptomatic neuro-endocrine
cancers. The authors present in this
report the case of a patient who has
been enjoying 10 years of cancer-free
survival after liver transplantation as
rescue therapy for acute liver failure
after liver resection for isolated
hepatic metastasis of colon adeno-
carcinoma. This case shows that in
some highly selected cases, liver
transplantation may be curative in
patients with liver metastases of
colon carcinoma.
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LT is performed for secondary or even large primary
(hepatocarcinoma or cholangiocarcinoma) liver tumours,
early cancer recurrence is common and usually very
aggressive. Results of these procedures are dismal, and
LT is not a recognized therapy for secondary liver can-
cer, with the exception of symptomatic neuro-endocrine
liver metastases [1, 2].
However, this case shows that long-term recurrence-
free survival may be possible in patients undergoing LT
for hepatic metastases of colon adenocarcinoma. In this
particular patient described above, who was the only
patient to have undergone transplantation for this
indication in the authors’ 15 years of LT experience,
prognosis factors for cure after liver resection were
good, since the metastasis was unique and the primary
tumour showed a well-diﬀerentiated adenocarcinoma
without lymph node involvement.
LT might therefore be curative in highly selected
patients with secondary liver cancer, especially in the
setting of newer and more eﬀective chemotherapy
agents. However, the number of patients with liver
metastases that are unsuitable for liver resection but
suitable for transplantation is probably very low. Rescue
transplantation after large liver resection that is com-
plicated by liver failure might be the most frequent
clinical situation in this setting.
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Fig. 1 Magnetic resonance imaging of the 5-cm liver metastasis
(black arrow) in segment VIII
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